Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria

被引：12

作者：

Ho, Soo Yei ^{[1
]}

Wang, Weiling ^{[1
]}

Ng, Fui Mee ^{[1
]}

Wong, Yun Xuan ^{[1
]}

Poh, Zhi Ying ^{[1
]}

Tan, Sum Wai Eldwin ^{[1
]}

Ang, Shi Hua ^{[1
]}

Liew, Si Si ^{[1
]}

Wong, Yin Sze Joyner ^{[1
]}

Tan, Yvonne ^{[1
]}

Poulsen, Anders ^{[1
]}

Pendharkar, Vishal ^{[1
]}

Sangthongpitag, Kanda ^{[1
]}

Manchester, John ^{[2
,3
]}

Basarab, Gregory ^{[2
,4
]}

Hill, Jeffrey ^{[1
]}

Keller, Thomas H. ^{[1
]}

Cherian, Joseph ^{[1
]}

机构：

[1] Expt Therapeut Ctr, 13 Biopolis Way, Nanos 13866, Singapore

[2] AstraZeneca, 35 Gatehouse Dr, Waltham, MA 02451 USA

[3] Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA

[4] Univ Cape Town, Dept Chem, H3D,PD Hahn Bldg,Upper Campus, ZA-7700 Rondebosch, South Africa

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2018年 / 157卷

关键词：

Gram-negative bacteria; Dual target inhibition; Gyrase B; ParE; Gyrase; TopoIV; TOPOISOMERASE-IV PARE; PSEUDOMONAS-AERUGINOSA; DNA; SUBUNIT; AVIBACTAM; SPECTRUM; BROAD; GYRB;

D O I：

10.1016/j.ejmech.2018.08.025

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Even though many GyrB and ParE inhibitors have been reported in the literature, few possess activity against Gram-negative bacteria. This is primarily due to limited permeability across Gram-negative bacterial membrane as well as bacterial efflux mechanisms. Permeability of compounds across Gramnegative bacterial membranes depends on many factors including physicochemical properties of the inhibitors. Herein, we show the optimization of pyridylureas leading to compounds with potent activity against Gram-negative bacterial species such as P.aeruginosa, E.coli and A.baumannii. (C) 2018 Elsevier Masson SAS. All rights reserved.

引用

页码：610 / 621

页数：12

共 37 条

[1] PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution
Adams, Paul D.
Afonine, Pavel V.
Bunkoczi, Gabor
Chen, Vincent B.
Davis, Ian W.
Echols, Nathaniel
Headd, Jeffrey J.
Hung, Li-Wei
Kapral, Gary J.
Grosse-Kunstleve, Ralf W.
McCoy, Airlie J.
Moriarty, Nigel W.
Oeffner, Robert
Read, Randy J.
Richardson, David C.
Richardson, Jane S.
Terwilliger, Thomas C.
Zwart, Peter H.
[J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 : 213 - 221
[2] Towards automated crystallographic structure refinement with phenix.refine
Afonine, Pavel V.
Grosse-Kunstleve, Ralf W.
Echols, Nathaniel
Headd, Jeffrey J.
Moriarty, Nigel W.
Mustyakimov, Marat
Terwilliger, Thomas C.
Urzhumtsev, Alexandre
Zwart, Peter H.
Adams, Paul D.
[J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2012, 68 : 352 - 367
[3] [Anonymous], 2015, Med Lett Drugs Ther, V57, P79
[4] [Anonymous], 2015, MED LETT DRUGS THER, V57, P31
[5] Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents
Basarab, Gregory S.
Manchester, John I.
Bist, Shanta
Boriack-Sjodin, P. Ann
Dangel, Brian
Illingworth, Ruth
Sherer, Brian A.
Sriram, Shubha
Uria-Nickelsen, Maria
Eakin, Ann E.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (21) : 8712 - 8735
[6] Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons):: a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase
Bellon, S
Parsons, JD
Wei, YY
Hayakawa, K
Swenson, LL
Charifson, PS
Lippke, JA
Aldape, R
Gross, CH
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (05) : 1856 - 1864
[7] Bisacchi G.S., 2015, CURR TOP MED CHEM, V1, P4
[8] 10 x '20 Progress-Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
Boucher, Helen W.
Talbot, George H.
Benjamin, Daniel K., Jr.
Bradley, John
Guidos, Robert J.
Jones, Ronald N.
Murray, Barbara E.
Bonomo, Robert A.
Gilbert, David
[J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (12) : 1685 - 1694
[9] Structure-Based Discovery of Substituted 4,5′-Bithiazoles as Novel DNA Gyrase Inhibitors
Brvar, Matjaz
Perdih, Andrej
Renko, Miha
Anderluh, Gregor
Turk, Dusan
Solmajer, Tom
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (14) : 6413 - 6426
[10] Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase
Ehmann, David E.
Lahiri, Sushmita D.
[J]. CURRENT OPINION IN PHARMACOLOGY, 2014, 18 : 76 - 83

← 1 2 3 4 →